From the recent and emerging concerns for approving lentiviral vector-mediated gene transfer in human clinical applications, several analytical methods have been applied in preclinical models to address the lentiviral vector load in batches, cells or tissues. This review points out the oldest generation methods (blots, RT activity, standard PCR) as well as a full description of the newest real-time quantitative PCR (qPCR) applications. Combinations of primer and probe sequences, which have worked in the lentiviral amplification context, have been included in the effort to dress an exhaustive list. Also, great variations have been observed from interlaboratory results, we have tempted to compare between them the different analytical methods that have been used to consider (i) the titration of lentiviral vector batches, (ii) the absence of the susceptible emerging replicative lentiviruses or (iii) the lentiviral vector biodistribution in the organism. Gene Therapy (2005) 12, S36-S50.
Introduction
Lentiviral-derived transfer vectors have gained increased attention because their karyophilic properties allow their use for the transduction of quiescent cells. 1, 2 The acceptance of their use in clinical settings will require profound and vigorous assays in order to evaluate the quality as well as the quantity of lentiviral particles in vector batches.
Validation and safety tests that will be required for the use of lentiviral vectors in human gene transfer should include (i) the search for susceptible emerging replicating forms (assays for replication-competent lentiviruses (RCL)), (ii) several sterility tests in order to detect remnants from mycoplasma, fungi or bacteria as well as contaminants originating from adventitious agents, (iii) the determination of the viral vector titers as well as (iv) in vivo preclinical studies for demonstrating the proof of complementation concept. In addition, the organ biodistribution of lentiviral vectors should also be addressed.
In this concern, GenoSafe s www.GenoSafe.com, a service company, has been recently founded by Genethon to provide gene transfer safety and quality tests for preclinical and clinical studies. Overall, this company is dedicated to vector characterization, containing titration and replication-competent virus experiments as part of quality control for preclinical products, and safety, preclinical in vivo studies, as well as gene therapyspecific patient follow-up. GenoSafe s operates under validated GLP conditions. This review points out the major progress undertaken for the standardization of some of these technical expertises. Associated with conventional detection methods, techniques derived from qPCR have been applied in the lentiviral vector context for the evaluation of titration, RCL and biodistribution in animal models.
Description of pre-existing lentiviral vector titration methods
The main options for titering lentiviral vectors include assessment of the reverse transcriptase (RT) activity and the viral RNA content in supernatants, as well as the number of proviral DNA and the efficacy of transgene expression in transduced target cells. Specifically dedicated to lentiviral vectors derived from the human immunodeficiency virus (HIV), an enzyme-linked immunosorbent assay (ELISA) directed against the p24 capsid protein has also been routinely employed for vector titer determination.
Lentiviral vector titration from transgene protein expression
For lentiviral vectors containing a reporter transgene expression cassette, 'infectious' particles (ip) are usually determined by evaluating the percentage of target cells that express the transgene protein.
Depending on the type of reporter used, lentiviral 'infectious' units are defined in several ways. Colonyforming units are generally used for drug selection genes. 3 Relative luciferase units are defined for renilla as well as firefly luciferase gene activities. [4] [5] [6] The term of transducing unit used in the context of lentiviral vector gene transfer has been routinely employed, especially for the expression of living color and lacZ genes. 7, 8 Protocols for the determination of functional viral titers by drugresistance colony assay, expression of green fluorescent protein (GFP) and b-galactosidase staining can be found in Tonini et al. 9 Additionally, infectious titers of vectors containing nonreporter gene cassettes have been determined by FACS analysis using primary antibodies directed against the transgene protein. However, this application is limiting as it requires antibody for all type of transgene and because it is restricted to some specific cellular compartments, predominantly at the plasma membrane. Nevertheless, mild permeabilization of the plasma membrane has already been described to allow cellular antibody uptake and vector recognition within the cytoplasmic compartment. 10, 11 Several optimizations undertaken in some of these reporter genes have been addressed in the context of the lentiviral gene transfer. To improve the LacZ gene expression in mammalian cells, Anson and Limberis 12 have codon optimized the Escherichia coli LacZ gene. From this mutagenesis, they have observed a 15-fold increase in b-galactosidase expression as well as a fivefold enhancement in HIV-1 vector titers, apparently due to the new opportunity to detect transduced cells that did not highly express the transgene. Concerning the GFP reporter protein, a lower cytotoxic mutant (from the sea pansy Renilla reniformis) has been compared to the original enhanced GFP (eGFP) from the jellyfish Aequorae victoria. However, in vivo lentiviral gene transfer studies did not show a clear advantage in term of cytotoxicity of this newly used GFP. 13, 14 Whereas one report has shown evidence of rejection in the retinal epithelium of rats when using the eGFP reporter transgene, 15 Duisit et al 13 did not observe neither sign of rejection nor difference in the long-term expression. In addition, although cytotoxicity has been observed after intracorneal injection of cats, it was only noticed in conditions where the eGFP protein has been overexpressed, and was solved by lentiviral vector dose reduction. 14 
Lentiviral vector titration from RT activity
The first generation of RT assays measures the incorporation of radiolabelled deoxyribonucleoside triphosphates into DNA using viral genomic RNA as template. 16 The quantity of incorporated radiolabelled nucleotides is then measured by a scintillation counter or by autoradiography. This RT protocol dedicated for retroviral and lentiviral vector titration can be found in Tonini et al. 17 An additional radiolabelled technique has also been developed where the detection system relied on hybridization of newly synthesized cDNAs by Southern blotting. 18 To circumvent the use of radiolabelled elements, nonradioisotopic assays have been conducted. They are based on the incorporation of digoxigenin-labelled dUTP during the RT step followed by conventional biotin/ peroxidase secondary reactions. 19 To increase the signal detection, therefore allowing the specificity improvement of RT-based assays, product-enhanced RT (PERT) assays have been designed, where neosynthesized cDNAs were further amplified by standard PCR. [20] [21] [22] [23] Newest PERT generations have also been performed in the design of qPCR by the addition of Taqman-based fluorescent oligonucleotide probes. [24] [25] [26] Whereas the sensitivity of first generation RT assays ranges from 10 4 to 10 6 viral particles, 27 it decreases to 1-10 virions when PERT assays are used. 18, 20, 21 Such assays, which are based on the endogenous RT activity of retrovirions, have been commonly employed for the verification of the absence of retroviral-based adventitious viruses in different biological materials, 28 ,29 but they have also served for isolating lentiviral packaging cell clones able to secrete functional empty capsids, where the term 'functional' argued for RT encapsidation. 30 By comparing different analytical methods for the titration of lentiviral vectors derived from the equine infectious anemia virus (EIAV), Martin-Rendon et al 31 have shown that there was no correlation between PERT assays and eGFP titers, by contrast to the results obtained with a RT-PCR titration method (cf Quantification of viral RNA genomes).
HIV-1-based vector titration from capsid content measurement
The assay commonly used for titering HIV-1-derived vectors that do not contain a reporter gene cassette is based on an ELISA test directed toward the capsid protein (p24). This approach is generally used to determine the number of 'physical' particles (pp), but is limited by the variable amount of free, nonparticleassociated p24 proteins that are produced by standard plasmid cotransfection methods of lentiviral production.
Based on the estimation that a HIV core particle is composed of around two thousands capsid proteins, 32 1 fg of p24 therefore represents around 12 pp. From this calculation, it is therefore able to depict the ip/pp ratio for any HIV-1-based lentiviral vector production, as from the moment when ip titer measurements are possible. The ip/pp ratio estimation is routinely employed for quality control validation of the different batches being produced. In fact, it allows the rejection of vector batches having a too great quantity of non-ip, which may result from gag-pol polyprotein overexpression and/or maturation problems. Although concrete specifications are not formally described in the litterature, it is generally accepted to consider that a relevant lentiviral vector batch is defined when the ip/pp ratio is contained in a window of 1/100-1/1000.
Lentiviral vector titration from viral nucleic acid detection
In the absence of marker genes, lentiviral vector titers expressing therapeutic genes have to be determined by alternative methods. Semiquantitative Northern blotting experiments have been used to estimate the particle number in lentiviral supernatants. 33, 34 In a concern to generate and isolate stable producer cell clones, some laboratories have also conducted screening experiments on retroviral supernatants by the use of dot blot assays. 35, 36 However, that kind of blotting assays cannot be employed to exactly quantitate the viral RNA content. Moreover, they generally acknowledged to greatly overestimate functional viral titers.
Semiquantitative Southern blotting has been described for the detection of proviral DNA genomes. 37 In addition, competitive RT-PCR and standard PCR have been qPCR applied to lentiviral analytical assays C Delenda and C Gaillard applied for a more exact quantitation of viral RNAs and proviral DNAs, respectively. 38, 39 Interestingly, nucleic acid testing (NAT) methods have been certificated by suppliers for HIV diagnosis such as nucleic acid-based sequence amplification (NASBA, Organon Nuclisens RNA assay), 40 branched DNA (bDNA, Chiron Quantiplex and Bayer Versant RNA assays), 41, 42 or transcription-mediated amplification (TMA, Gen-Probe RNA assay). 43 The main reason why these assays have not been used for the titration of nonreplicating HIV vectors reside upon the fact that their target sequences, which are mostly derived from viral genes, are no longer present in the recombinant transfer vector genomes.
Description of the different qPCR-based methods applied to lentiviral vector titration Real-time qPCR is an important scientific advancement that greatly extends the usefulness of PCR technology. It facilitates the monitoring of the reaction as it progresses. One can start with minimal amounts of nucleic acid and quantify the end product accurately. Moreover, there is no need for the post-PCR processing which saves the resources and the time. These advantages of the fluorescence-based qPCR technique have completely revolutionized the approach to PCR-based quantification of DNA and RNA. Real-time assays are now easy to perform, have high sensitivity, more specificity, and provide scope for automation.
The fluorescent reporter molecules include dyes that bind to the double-stranded DNA (ie SybrGreen I) or sequence-specific probes (ie TaqMan, molecular beacons or Scorpion probes). Taqman-and SybrGreen I-based qPCR strategies have already been used in the design of lentiviral vector titrations, where different viral nucleic acid species have been successfully quantified, such as viral RNAs, 31, [44] [45] [46] [47] and 'strong stop' minus strand cDNAs, 44, 48 in vector batches, as well as proviral DNAs, 31, 44, 45, 47, 49, 50 and transgenic mRNAs in transduced target cells. 47, 51 This chapter tempts to highlight and compare between several laboratories and different analytical assays the principal titration results they have obtained. All qPCRbased assays that have been developed to date for lentiviral vector titrations are summarized in Table 1A . Primers/probe location and sequences related to lentiviral-derived transfer vector genomes are designed either on endogenous (LTR, primer-binding site), encapsidation signal) or exogenous (eGFP transgene, cytomegalovirus (CMV) promoter, WPRE) DNA elements.
In addition, Table 1A also shows several primers/ probe sets that have been used for different control testing experiments. These include (i) the amplification of human cellular endogenous genes (b-actin and albumin DNA sequences) for exactly measuring, after transduction, the number of proviral genomes per target cell, (ii) the verification of the absence of plasmid DNA remnants in transduced cells (amplification of the ampicillin gene) or (iii) the exact measurement of the concentration of genomic DNA extracts (amplification of the human mitochondrial DNA).
In an attempt to depict solid conclusions, we have decided to compare between them the different analytical titration methods. Owing to the absence of comparison in some of these reports, it was therefore sometimes difficult to dress an exhaustive assessment.
Moreover, concerning the determination of eGFP titers, it should be important to take into consideration that result variations between laboratories are commonly observed since eGFP titers are dependent on the nature of the promoter used to express the transgene as well as on the cell type being chosen. A recent article has shown that the lentiviral vector titration varies with changes of conditions in the transduction process, including the inoculum volume, the type but also the number of target cells and the length of period of the vector adsorption to target cells. 52 They have shown that the variation of these parameters has resulted in a greater than 50-fold differences in the vector titer from the same vector stock.
In the same extent, transfer vectors that contain the central polypurine tract (cPPT) will give higher titers in transduced cells (eGFP and proviral DNA titers) as compared to vectors that do not have the cis-active nuclear translocation facilitator, and since not all laboratories have conducted their assays with such a sequence inserted in their lentiviral vector backbone, it was therefore difficult to depict solid conclusions. However, we have tried in this chapter to highlight the real benefit of qPCR-based assays for the standardization of lentiviral vector titration over classical existing techniques.
Concern for plasmid DNA carryover
Susceptible DNA contamination due to plasmid carryover from the lentiviral transfection process is generally eliminated by a DNA nuclease treatment. Depending on the source of the nucleic acid being amplified, this prior nucleasic incubation has been addressed directly on lentiviral vector preparations and on isolated viral RNAs to avoid plasmid DNA contamination in genomic DNA and viral RNA extracts, respectively.
Sastry et al 45, 53 have followed, after DNase I and benzonase treatments, the disappearance of plasmid DNA species, by amplifying by qPCR a plasmidic sequence, that is, an ampicillin (amp r ) DNA fragment. Although a large amount of the amp r gene was detected in vector supernatant, only a low percentage (o0.01%) of the plasmid DNA was transferred to cells upon vector transduction. The lack of plasmid contamination after DNase I treatment has also been confirmed in different lentiviral vector preparations by conducting standard PCR also directed against the amp r gene. 47 From the next mode of lentiviral vector production, which is based on the design of stable producer cell lines, of course, plasmidic DNA remnants in vector batches will not be anymore an impediment.
Measurement of viral nucleic acids within vector batches
Assessing titer in lentiviral vector supernatants is technically the easiest method and provides the most rapid turnaround. However, viral genome titration methods may not accurately reflect the functional titer due to the presence of defective interfering particles, inhibitors of transduction, and eventually carryover DNA from vector production when prior nuclease treatment was not a concern.
qPCR applied to lentiviral analytical assays C Delenda and C Gaillard Quantification of viral RNA genomes Viral genomic RNAs are isolated from lentiviral vector preparations and used as templates in one-step RT-qPCR reactions. To eliminate the participation of plasmid DNA background, RNA concentration is generally determined by substracting plasmid copy number in reaction runs without RT from those with RT. Such RT-qPCR titration assays have already been conducted in several laboratories. [44] [45] [46] [47] From all results gained, the number of vector molecules was in each case higher than that observed by the eGFP titration method (Table 1B) . This suggests a considerable disparity between the number of vector sequences and the number of vector particles able of successfully transducing target cells.
However, the level of amplitude is not identical between groups, varying to 200-to 10 000-fold increase. As already mentioned above, since the transgene expression can be affected according to the type of enhancer sequences (promoter, cPPT) that are present (or not) in the transfer vector genome as well as on the type of cell being transduced, it may participate to the overall variation observed. Additional intrinsic experimental factors may also contribute to the absence of correlation between eGFP and RT-qPCR titers, such as technical parameter deviations: primer/probe specificity, validity of the DNA concentration measurement, quality of the RNA extraction, hand-to-hand variations. Moreover, it has been shown that the RT-qPCR titration method severely overestimates functional titers because of the known presence of defective contaminating lentiviral particles, which can frequently outnumber functional particles by 20-fold or more. 33, 34 Since technical details for the lentiviral production design may vary between groups, differences in the particle formation and maturation will not be surprising.
In spite of the lack of homogeneity between groups, it has been, however, possible in the same report to compare RNA packaging and transduction efficiency for two different origins of lentiviral vectors, that is, Forward and reverse primers as well as probe sequences are indicated. In addition to the amplification scheme of DNA elements contained in lentiviral genomes (3rd raw), additional primer and probe sequences that are used as controls are also noticed in the last raw. Numbers in parentheses indicate nucleotide positions in the HIV-1 viral genome (1) or in human cDNAs. (2) Nucleotide positions referred to cis-acting sequences (CMV promoter, WPRE) are not given since their sequence delimitation is not identical according to different Genbank accession numbers. Relative to the Taqman-based design, fluorophores added in the 5 0 -and 3 0 -ends of probe sequences are also indicated; F: 6-FAM, T: TAMRA, V: VIC, Te: TET. For assays where no probe sequence is listed, the amplification signal is given by the incorporation of the SybRGreen I binder agent. qPCR applied to lentiviral analytical assays C Delenda and C Gaillard HIV-1-and EIAV-related genomes. 46 In fact, the direct comparison between both vectors has permitted to show that although the amount of RNA packaged was similar, EIAV-based vectors were 20-fold less efficient for transduction in human cells. In the context of EIAVderived gene transfer, another report has also confirmed the positive correlation between this RNA-based titration approach and eGFP titers. 31 Concerning the RNA packaging efficiency in HIV-1 vector virions, Lizée et al 47 have shown that it is dependent on the nature of the transgene being expressed in producer cells. Lentiviral transfer vectors that encode cytotoxic transgenic proteins, that is, tumorassociated antigens and neo-poly(A) polymerase, have consistently lower genomic RNA titers as compared to an eGFP-expressing reference vector.
Quantification of strong stop cDNAs
Before retroviral entry into the cell, RT of the viral RNA genome is initiated in virion particles. In this endogenous step, the RT reaction, primed by the primer-binding site anchored tRNA, starts by minus (À) strand cDNA synthesis, through R-U5, and leads to the formation of (À) sense cDNA species. Therefore, the viral RNA load present in any vector batch can be indirectly estimated by measuring the amount of these encapsidated cDNAs. Amplification of these so-called 'strongstop' cDNA species has been addressed in lentiviral vector particles, 44 by reproducing what have been previously performed for an oncoretroviral vector titration design. 48 By comparing this DNA-based method to the previously reported RT-qPCR approach (cf Quantification of viral RNA genomes), Scherr et al 44 have shown that the number of viral particles measured was similar, with only twice as many particles detected when the RT-qPCR assay was used (Table 1B) . This difference may be due to the fact that not all lentiviral cores contain the strongstop cDNA. 54 In fact, some experimental conditions during the production scheme, for example high confluency, cause differences in the pool of free nucleosides available in producer cells, therefore abrogating or allowing partial endogenous RT process in some viral cores. From this latter event, uncompletely reversetranscribed cDNAs, that have been termed 'weak-stop' cDNAs, have been observed in wild-type HIV-1 virions. 55 
Measurement of proviral DNA genomes within transduced target cells
In the most majority of the assays already been conducted, lentiviral vector integration events have been calculated by normalizing the number of proviral molecules to the number of target cells, by a parallel or duplex quantification of an endogenous cellular gene (cf Table 1A ), such as DNA fragments derived from human albumin, 44, 50 or b-actin genes.
31
Quantification of total proviral copies per cell
Quantitation of proviral DNA in transduced target cells is likely to provide a more accurate measurement of viral titer than assessing viral particles released by producer cells, because only transduction-competent recombinant vectors will be detected by this method. The majority of laboratories, who have already developed a RNA-based analytical method, have also qPCR applied to lentiviral analytical assays C Delenda and C Gaillard addressed, by qPCR, the possibility to determine the lentiviral vector titration by measuring the number of proviral molecules per target cells (Table 1C) . With the exception of one laboratory which obtained roughly similar titer results to standard reporter gene (eGFP and RFP) titration, 44, 51 the other data in the literature suggest, in any case, that DNA proviral-based qPCR assays overestimate eGFP titers, varying from sixto 60-fold. 31, 45, 47, 49, 50 The major differences were observed in Sastry et al, 45 where a 60-fold variation was noticed according to the type of promoter used.
The difference observed between these two analytical titration methods could be explained by the fact that not all proviral DNA molecules correspond to transcriptionally active forms. These qPCR assays are amenable to detect in transduced cells the totality of proviruses that corresponds to unintegrated linear and circular molecules as well as integrants. The common idea that many retrovirologists thought from the past, that consists to consider that circular proviral genomes are transcriptionally incompetent, has been recently reconsidered. In the context of vectors derived from HIV-1 or feline immunodeficiency virus, integrase-defective mutants have been shown to be able to deliver the transgene signal, 56 suggesting the participation of unintegrated DNA proviral forms in the transcription process. Although these unintegrated proviruses could interfere to the exact titer measurement, they probably exert their effect in a low extent since the number of such DNA species is in minority at the time where DNA extracts were isolated (cf Evaluation of the disappearance overtime of circle proviral genomes). Therefore, the major reason for overestimating the number of transducingcompetent particles will preferably be explained by the proviral integration in heterochromatin regions, where highly condensed structures do not allow transgene transcription.
Quantification of integrated proviral copies per cell
Detection of integrated proviruses has been accomplished, in the context of HIV-1 gene transfer, by amplification with primers complementary to LTR and chromosomal Alu repeats (Table 1C) . 49 Integrated viral DNA was detectable by 24 h post-transduction (p.t.) and reached a plateau by 48 h p.t. By comparing the number of integrated proviruses over the one obtained after the amplification of total proviral DNAs, the authors have shown that not all proviruses were converted to integrated copies. The rate of fall of the amount of total proviruses was greater than could be accounted for by dilution during cell growth, indicating that the viral DNA was probably degraded by host cells. The robustness of this assay has been confirmed by Southern blotting which seemingly reflected the same number of integrated proviruses. 
HIV-1
Three different assays have been designed in order to detect several types of proviruses (total, integrated or 2-LTR circles).
qPCR applied to lentiviral analytical assays C Delenda and C Gaillard
The kinetic results have been confirmed by another laboratory which had used a similar Alu-LTR amplification design. 57 In addition to this confirmation, the authors have shown that integration of HIV-1 DNA was detected as early at 12 h p.t. and that the integrated proviral DNAs accounted for about 5% of the initial viral DNA synthesis.
As a result of the low frequency of Alu repeats in the human genome -approximately one Alu repeat every 5000 bp -one may argue that not all integrated proviral genomes could be detected. Moreover, it is well known that the real-time qPCR method works better with very low DNA distances. In addition, because of the intrinsic unidirectional design of the Alu primer, only half of Alu repeats could be detected.
Evaluation of the disappearance overtime of circle proviral genomes
By taking advantage of the intrinsic molecular nature of the 2-LTR circles that allows the tandem orientation of LTRs, Butler et al 49 have designed a qPCR assay for evaluating overtime the number of such unintegrated proviruses (Table 1C) . They have shown that the 2-LTR circles peaked at 24 h p.t. and declined thereafter. The production of 2-LTR circles has been slightly increased by prior incubation of transduced cells with integrase inhibitors, probably because blocking integration provides more substrate for ligation to form 2-LTR circles. 57 Although it is interesting to get some information from 2-LTR proviruses, however, general conclusions concerning total unintegrated circles cannot be dressed since the ratio of 1-LTR to 2-LTR circles has been estimated of around 9:1.
49,57 Nevertheless, Van Maele et al 57 have shown, from their qPCR assay, that the 2-LTR circles represented only 0.7% of the total viral DNA present and that the impact on nuclear import was evidenced by a three-fold increase after transduction with cPPT vectors.
Choice of DNA standard curves
The amount of proviral molecules within a cell and the amount of cell genome in the sample are determined according to plasmid DNA curves. It may be argued that, in some specific context, amplifications with genomic DNA extracts cannot be extrapolated to those established with a plasmid DNA curve.
As a first example, if the work presented in chapter Quantification of integrated proviral copies per cell, that concerns proviral integration measurement, has been possible, it only resides on the fact that the authors have used, for the Alu-LTR curve, DNA extracts from a transduced bulk cell population. 49, 57 In fact, since retroviral integration can occur at many location sites in the human genome, each provirus has a unique distance to the nearest Alu sequence and therefore generates amplification products of variable lengths. To be able to quantitate the number of integrated proviruses per target cell, the DNA standard curve must represent the full distribution of distances between LTRs and flanking Alu elements.
In a second concern, one may argue that the quality of DNA extraction between genomic and plasmidic elements is not comparable. Since some remnants from these extracts can participate as susceptible PCR inhibitors, they could have a different impact level as they originate from prokaryotic (plasmid) or eukaryotic (mammalian cell) species. From our earlier described SybrGreen I-based qPCR model, 50 we have compared the standard plasmid DNA curve to genomic DNAs derived from transduced clonal cells. Figure 1 first shows the variation of the threshold cycle (C t ) as a function of plasmid DNA molecules that contain either the HIV-1 transfer vector backbone (A) or a human endogenous albumin sequence (B). A five-log linear relationship was noted over the range tested (10 3 -10 7 plasmid molecules), with correlation coefficients higher than 0.995. Figure 2a measures the copy number integrated in different clonal cells by using normalized values from plasmid DNA curves. Values calculated from this qPCR assay agree with the copy number estimated by Southern blot (Figure 2b ), suggesting that there is no difference in amplification regarding the quality and origin of DNA, for example genomic versus plasmidic DNAs.
Analysis of the transgene mRNA expression
For future applications, it will be essential not only to accurately determine the transducing titers of lentiviral vector preparations but also to assess the transgene expression in transduced target cells.
In such an attempt, Lizée et al 47 have taken advantage of their qPCR-based assay -that is, primers/probe set derived from the cis-active WPRE sequence that is still present in the 3 0 mRNA extremity -to apply it for the quantitation of transgene transcripts. In a RT-qPCR format, the copy number of a cellular endogenous mRNA, that is, from the human b-actin gene (cf Table  1A ), was measured simultaneously as a normalization control. By analyzing lentiviral transgene expression at the mRNA level, they have observed functional differences between three distinct lentiviral vectors that express different kind of transgene. Messenger RNA expression from neo-poly(A) polymerase cDNA has been shown to be 56-fold lower than that of eGFP transcription, despite only a three-fold difference in proviral DNA . The threshold cycle (C t ) corresponds to the cycle number at which the amplification has reached half the threshold value.
qPCR applied to lentiviral analytical assays C Delenda and C Gaillard titer. Presumably, toxic effects resulting from overexpression of a normally tightly regulated gene product could select for overgrowth of transductants expressing relatively low levels of transgene.
Very recently, the analysis of small-interfering and small-hairpin RNAs delivered from lentiviral proviruses has also been monitored by a RT-qPCR assay. 51 By using different primers/probe sets specific of the bcr-abl oncogene, the authors have measured the level of expression of these RNA polymerase III-dependent RNAs in a cell depletion model.
Description of qPCR-based methods for others lentiviral-derived analytical assays Development of RCL assays
Lentiviral vectors have demonstrated exceptional promise as tools for gene therapy applications, but have also raised safety concerns because of potential creation of RCL by uncontrolled recombination.
All assays already been conducted consist in the amplification of RCL by culturing vector-containing supernatant on a permissive cell line and require the use of an internal replicative control. In order to increase the stringency of RCL assays, some laboratories have associated to the standard detection of gag-pol-env replicative particles the alternative possibility to discriminate gag-pol recombinants by amplification in permissive cells that express an envelope glycoprotein, such as the one derived from the vesicular stomatitis virus (VSV/G). 32 Specifically dedicated to HIV-1-derived lentiviral vectors, several methods have been designed for the follow-up of susceptible emerging tat recombinants (tat transactivation test), [58] [59] [60] as well as gag recombinants (p24 enzyme-linked immunosorbent ELISA assay). [61] [62] [63] [64] These assays only detect gene products and not actually RCL; the second assay is thought to be relatively insensitive, and none have been tested or validated.
On the model of what has previously been carried out for oncoretroviral vectors, additional methods related to any lentiviral genus have been proposed to detect RCL such as standard PCR, 3, 65 transgene signal follow-up, 66 or marker rescue assay. 64, [67] [68] [69] The latter method is based on the mobilization of a proviral genome by susceptible gag-pol-env recombinants and therefore should represent the most appropriate assay by its ability to mimics all trans-active packaging functions. Moreover, this assay is very sensitive and discriminates replication-defective virus from RCL, generating a compelling need for its standardization and validation.
Although the mobilization/marker rescue assay has been extensively employed for the agreement of retroviral vector batch release, the parallel development of nucleic acid-based methods such as standard PCR or qPCR may probably be a relevant alternative to confirm the absence of any type of recombination. In parallel to the interest to follow the decrease of the capsid p24 protein after successive passages of HIV-1-based vectors in permissive cells, some laboratories have also designed qPCR assays to certify the absence in DNA genomic extracts of the VSV/G envelope gene (Table 2 for primers/probe designs). 65, 70 Since the appropriate positive control cannot be available with such an ubiquitous envelope gene inserted in the proviral genome because of safety concern, it was therefore difficult to clearly evaluate the robustness of these assays. However, the sensitivity of VSV/G detection has been estimated to be around five to 10 copies. Surprisingly, RCL assay cultures contained an initial level of VSV/G sequence, depending on the original vector concentration, 65 as it was noticed in chapter Concern for plasmid DNA carryover, this was most likely due to the presence of residual plasmid DNA originating from the transient transfection procedure of vector production. This initial level decreased gradually to reach the limit of detection within the 35 days of the assay. No increase in the VSV/G concentration has been observed in any of HIV-1 vector batches, indicating that no VSV/G propagation caused by the replication of a recombinant virus had occurred in the cultures tested.
From their respective discussion, the authors claimed that the VSV/G qPCR end-point analysis could not replace existing RCL assays but suggested that it should remain a complementary informative assay for the discrimination of gag-pol-VSV/G recombinants. Southern blotting was realized after cutting the human genome with a restriction enzyme (BamHI) that only cuts once in the proviral genome; proviral-host DNA fragments were detected by using a radioactive probe directed against the eGFP gene.
Biodistribution studies
The tissue biodistribution in animal models is an important aspect for characterizing new transfer vectors and has been defined as an essential tool for analysis by regulatory agencies, such as the Food and Drug Administration (FDA) or the Recombinant Advisory Committee from the National Institute of Health's, in order to approve downstream human gene therapy trials. [71] [72] [73] High sensitivity and reproducibility of such assays are of major concern for successful biodistribution studies, especially when very low gene transfer is anticipated.
To satisfy such requirements, PCR-related DNA analysis has been specified by the FDA as an adequate method for the transduction survey in animals. 72, 74 Although gene transfer and transgene expression of lentiviral vectors have been demonstrated by several laboratories in various organs, 58, [75] [76] [77] [78] the biodistribution and systemic effects have not yet been fully addressed.
Nevertheless, different groups have already initiated that kind of expertise, where the common measurement analyses for determining which organ is targeted are based either on reporter protein expression profiles, [79] [80] [81] or on the detection of proviral DNA elements by using standard PCR, 80 fluorescence in situ hybridization, 82 or qPCR amplification method. [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] As equivalent to the in vitro strategy (cf Measurement of proviral DNA genomes within transduced target cells), most of these qPCR-based assays measured the number of proviral copies per target cell by normalizing it to the number of endogenous gene amplicons. In Table  3 are summarized primers and probes dedicated for parallel or duplex amplifications of lentiviral DNA proviruses and fragment DNAs derived from animal genomes.
Tail-vein injection of VSV/G-pseudotyped HIV-1 vectors in BALB/c mice has resulted, at 40 days postinjection (p.i.), to a very high gene transfer in the bone marrow, ranging from 0.21 to 22.7% of transgene frequency determined by qPCR amplification. 83 This result was consistent with the observation that high eGFP protein levels (410%) were detected in peripheral blood leukocytes from these animals. Additional organs have also been transduced but to a lesser extent: liver (0.26-1.3%), spleen (0.045-0.38%), bladder (0-0.85%), lung (0-0.30%), heart (0-0.021), brain (0-0.16%), kidney (0-0.003%) and gastrointestinal tract (0-0.004%).
In other reports that have also based their biodistribution studies upon the real-time PCR technique, intravenous (i.v.) injection of VSV/G-pseudotyped lentiviral particles, whether they are derived from HIV-1, 92, 93 or EIAV, 91 have led to a better transduction signal in the liver and spleen.
Real-time PCR analyses have also been performed after intraperitoneal (i.p.) injection of a VSV/G-pseudotyped HIV-1 vector preparation in immunocompromised mice (SCID), 94 showing that the vector sequence was also detected predominantly in the liver (0.1-1%) and the spleen (0.8-2%).
A recent model for in vivo cell targeting of HIV-1 vectors pseudotyped with a modified chimeric Sindbis virus envelope glycoprotein (named m168) has also been assessed with a qPCR monitoring. 90 By using this type of pseudotyping, the authors have shown, after i.v. vector delivery in a mouse melanoma cancer model, a substantially lower infectivity in the liver and spleen, with successfully targeted metastatic melanoma cells growing in the lungs.
Fleury et al 85 have evaluated the ability of VSV/Gpseudotyped HIV-1 vectors to transduce the myocardium of rats. At day 3 after intramyocardial injection, the qPCR analysis performed on genomic DNAs showed around 10% of cardiac cells being transduced, with half of them expressing the eGFP reporter protein. Proviral DNAs declined thereafter, upon day 14 and week 10 analyses, by three-to five-fold. In parallel, systemic vector dissemination was also evaluated; small amounts of HIV-1 proviruses have only been detected in the liver (0.0003%) and spleen (0.007%), probably attributable, according to the authors, to inadvertent vector injection into the cardiac circulation or to susceptible migration of cardiac leukocytes to remote organs.
Biodistribution studies have also been attempted in BALB/c fetuses by intramuscular and intrahepatic (i.h.) injections of HIV-1 vectors pseudotyped by different glycoproteins. 84 From the results gained by their nonnormalized qPCR assay, the authors have shown that the efficiency and distribution of transduction was highly dependent upon the route of administration and the The susceptible detection of VSV/G recombinant DNA is performed in DNA genomic extracts from transduced permissive cells at late passages. Numbers in parentheses indicate nucleotide positions in the VSV/G cDNA. (3) qPCR applied to lentiviral analytical assays C Delenda and C Gaillard pseudotype of vector used. A widespread distribution of vector sequences has been observed in multiple tissues but mainly in the liver, heart and muscle. Overall, hepatocytes were better transduced with the VSV/G pseudotype, whereas myocytes were preferably targeted with Mokola or Ebola glycoproteins.
In another fetal model (rhesus macaque), however, no significant differences have been found in the level of eGFP gene marking when comparing i.p. and i.h. routes of HIV-1-derived lentiviral vector administration. 89 At 7 months after vector delivery, the percentage of gene transduction was higher in abdominal organs (omentum (1.7%), diaphragm (1.4%) and peritoneum (0.6%)) as compared to nonabdominal organs (thorax (0.8%), trachea, esophagus, lung and pericardium (0.05%), cerebrum, heart, thymus and bone marrow (o0.005%)). Interestingly, the authors have also designed a RT-qPCR assay, as already described above for in vitro transcript analysis (cf Analysis of the transgene mRNA expression), and have shown a positive correlation between gene (qPCR) and mRNA (RT-qPCR) biodistribution. Since differences may exist in the level of gene transfer and expression from two different specimens from the same tissue, the authors have chosen to determine the amount of eGFP transgene and mRNA transcripts present in the same specimen.
One of the most important concerns for in vivo gene therapy in humans is the possibility of germline integration, which might result in the introduction of heritable genetic changes into the offspring of treated patients. Insertional mutations that lead to devastating consequences have already been reported in the germ line of transgenic mice produced by pronuclear microinjection. 95, 96 From the distribution reports that have been discussed above, vector sequences in gonad organs were either undetectable, 85 or rarely scored as barely detectable levels. 83, 84 Nevertheless, Jimenez et al 89 have observed from i.v. vector delivery some significant gene scoring in male (0.0034%) and female (1.5%) gonads of macaque fetuses.
Ex vivo applications have also been monitored by the real-time PCR assay in order to know which differentiated cells are scored after engraftment and in how many copies per colony. Autologous CD34+ cells transduced with SIV-derived lentiviral vector preparations have been engrafted in three rhesus macaques. 88 Here again, the authors have observed a clear correlation between gene marking (qPCR) and gene expression (FACS) from different reconstituted cell lineages. In a mouse model for Fanconi anemia disease, Yamada et al 86 have shown that one proviral copy per cell was detected in all lineage-committed cells in the peripheral blood of both primary and secondary recipients, allowing the phenotypic correction by ex vivo lentiviral-mediated transgenesis. In the concern of reducing the number of integrated proviral copies in repopulated cells, Kurre et al 87 have identified conditions for lentiviral gene transfer involving minimal ex vivo target cell manipulation. From the results gained by qPCR monitoring, they have shown that the initial multiplicity of infection was a critical determinant of proviral copy number in transduced murine long-term repopulating cells.
Conclusion
Many laboratories, which are implicated in the lentiviral vectorology, have settled several qPCR-based analytical methods in order to measure and/or standardize the vector titration and its biodistribution in the organism. In addition, the qPCR assay has also been dedicated for the follow-up of susceptible emerging recombinants; qPCR applied to lentiviral analytical assays C Delenda and C Gaillard although additional techniques such as the marker rescue assay are better suited for RCL detection, the qPCR-related approach could be used in parallel to confirm functional results and also to evaluate the genetic structure of recombinants. All assays already being conducted to date in the lentiviral vector design have shown that the qPCR strategy is a robust and solid application with at least five-log over-range of magnitude. Most of the qPCRbased titration expertises have suggested a positive correlation with titers determined by the eGFP expression. However, titers derived from the measurement of the viral nucleic acid species (RNA genome and strongstop cDNA) in vector particles could only determine the number of pp contained in each lentiviral vector batch. By contrast, DNA proviral-based titration assays seem to be more consistent for the exact quantitation of the number of transducing-competent particles (ip).
The overall disparity observed between the different groups and assays suggest that laboratories should take into account the necessity to harmonize and standardize the lentiviral-based control testing in order to set up a liable and robust expertise from the next clinical trials that will be conducted in a near future. From discussions and exchanges, scientific experts in this field should gather their effort to decide which technique will be the gold standard.
